FDA Approves Second CAR-T Cell Therapy for Multiple Myeloma Patients, Furthering Patient Access to This Revolutionary Treatment

Updated March 2nd, 2022

FDA Approves Second CAR-T Cell Therapy for Multiple Myeloma Patients, Furthering Patient Access to This Revolutionary Treatment

close

Patient Pathfinder

We’re here to help. Have you had any treatment for myeloma yet?

You might want to check out some top experts outlining the initial treatment for myeloma.

Got it. Are you looking for maintenance treatment?

You might want to check out some top experts outlining maintenance treatment for myeloma.

Ok. Has your Myeloma come back? Here are some useful resources:

If you’ve had at least four treatments that have not worked or stopped working you might be a candidate for a treatment called CAR T Therapy.

NOW
PLAYING
Multiple Myeloma Warrior Misdiagnosed With A 'Pulled Muscle' For Months
NOW
PLAYING
Busy Nurse & Mom of 2 Thought She Had a 'Herniated Disk:' It Turned Out to be Multiple Myeloma
NOW
PLAYING
Comprehensive Biomarker Testing for Lung Cancer Points Docs to the Right Drug
NOW
PLAYING
New Drug Combo Shows Promise in Treating Relapsed Multiple Myeloma
NOW
PLAYING
Study Finds The Drug Ibrutinib Can Improve Outcomes In Some Newly Diagnosed Patients With Mantle Cell Lymphoma
NOW
PLAYING
Extremely Tired Mom Of Four, 54, Was Dismissed By Doctors As 'A Hypochondriac:' It Turned Out To Be Cancer
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.